The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Datopotamab deruxtecan (Dato-DXd) in Chinese patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC): Results from the phase 1/2 TROPION-PanTumor02 study.
 
Yuping Sun
No Relationships to Disclose
 
Zuke Xiao
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Juan Li
No Relationships to Disclose
 
Hai Yan Tu
No Relationships to Disclose
 
Jianlin Long
No Relationships to Disclose
 
Xiaoyan Lin
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Yan Wang
No Relationships to Disclose
 
Yuan Chen
No Relationships to Disclose
 
Rui Ma
No Relationships to Disclose
 
Yinglei Liu
Employment - AstraZeneca
 
Min Lu
Employment - AstraZeneca
 
Biao Zhang
Employment - AstraZeneca
 
Yi-Long Wu
Honoraria - AstraZeneca; BeiGene Beijing; Boehringer Ingelheim; Bristol-Myers Squibb/China; Hengrui Pharmaceutical; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Research Funding - BMS (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)